Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has been updated to reflect the latest version as v2.15.2, replacing the previous version v2.15.0. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.2%
- Check24 days agoChange DetectedThe page has been updated to reflect that it is currently active and not recruiting, with a new last update date of April 23, 2025. Additionally, the contact information for the study has been removed.SummaryDifference2%
- Check31 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and eligibility criteria for a clinical trial on acute heart failure, while adding a new version number and a reference to a specific study identifier.SummaryDifference35%
- Check39 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 17, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.5%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check96 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.